Targeting bile‐acid signalling for metabolic diseases
Open accessThe DOI matches its Crossref record; 165 of the 169 references it cites were found in a registry or an index.
Abstract
Bile acids are increasingly being appreciated as complex metabolic integrators and signalling factors and not just as lipid solubilizers and simple regulators of bile-acid homeostasis. It is therefore not surprising that a number of bile-acid-activated signalling pathways have become attractive therapeutic targets for metabolic disorders. Here, we review how the signalling functions of bile acids can be exploited in the development of drugs for obesity, type 2 diabetes, hypertriglyceridaemia and atherosclerosis, as well as other associated chronic diseases such as non-alcoholic steatohepatitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Through FXR activation, OCA modulates bile acid synthesis, absorption, transport, secretion, and metabolism, with a net effect of choleresis.(157,158)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“In animal models, FXR activation has demonstrated antifibrotic and anti-inflammatory properties as well.(157)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“After conjugation with either taurine or glycine, primary bile acids are released into the intestine to assist with lipid digestion and are recycled back into the liver (Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“By activating nuclear farnesoid X receptor (FXR) and plasma membrane TGR5 receptor, bile acids were shown to regulate systemic lipid, cholesterol, and glucose metabolism, as well as energy and immune homeostasis (Calmus and Poupon, 2014;de Aguiar Vallim et al., 2013;Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“In addition, FXR regulates other pathways with direct antiinflammatory and antifibrotic effects. 13-15”
From A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis (2016) · cites this paper as [13]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationThe Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Research works printed but not linked: 1
- Harnish, D. C. et al. A synthetic farnesoid X receptor (FXR) agonist protects against diet-induced dyslipidemia. J. Clin. Lipidol. 1, 362 (2007).
Cited by
Items 601–700 of 1,002
Role of the microbiome in the normal and aberrant glycemic response
Suez, J., Shapiro, H., & Elinav, E. (2016) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2016.01.001 · Cited by 32
Bile reflux and bile acids in the progression of gastric intestinal metaplasia
Qu, X., & Shi, Y. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002290 · Cited by 37
“Normally, hydrophobic bile acids are cytotoxic, while hydrophilic bile acids are cytoprotective.([16-18]) Bile acids act as ligands and exert their physiological effects by binding to nuclear membrane receptors, such as farnesoid X receptor (FXR),”
BackgroundRole of bile acids in overweight and obese children and adolescents
Giannini, C., Mastromauro, C., Scapaticci, S., Gentile, C., & Chiarelli, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1011994 · Cited by 32
“Lower ACC2 expression reduces the level of malonyl-CoA that inhibits the activity of carnitine palmitoyl transferase 1, the rate-limiting enzyme controlling the import of fatty acids into the mitochondrial matrix, increasing liver boxidation and brown adipose tissue mass (20).”
BackgroundInfluentialLiver’s influence on the brain through the action of bile acids
Yeo, X. Y., Tan, L. Y., Chae, W. R., Lee, D., Lee, Y., Wüestefeld, T., & Jung, S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1123967 · Cited by 38
“Deoxycholic acid (DCA), ursodeoxycholic acid (UDCA), and lithocholic acid (LCA) can be passively reabsorbed and further conjugated with taurine or glycine in the liver (Trauner and Boyer, 2003; Thomas et al., 2008).”
BackgroundYu, D. D., Sousa, K. M., Mattern, D. L., Wagner, J. E., Fu, X., Vaidehi, N., FORMAN, B. M., & Huang, W. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.048 · Cited by 35
Macrocyclic bile acids: from molecular recognition to degradable biomaterial building blocks
Gautrot, J. E., & Zhu, X. X. (2009) · Journal of Materials Chemistry · doi:10.1039/b821340b · Cited by 32
Molecular mechanisms of gut microbiota in diabetic nephropathy
Cheng, G., Liu, Y., Guo, R., Wang, H., Zhang, W., & Wang, Y. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111726 · Cited by 33
Assessing causal associations of bile acids with obesity indicators: A Mendelian randomization study
Huang, C., Xu, S., Chen, R., Ding, Y., Fu, Q., He, B., Jiang, T., Zeng, B., Bao, M., & Li, S. (2024) · Medicine · doi:10.1097/md.0000000000038610 · Cited by 33
“[30] The intestinal microbiota has the capacity to metabolize primary BAs into secondary BAs with increased hydrophobicity, such as deoxycholate (DCA) and lithocholate (LCA), which possess enhanced lipolytic properties and facilitate the digestion and absorption of fats.”
BackgroundFocus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
Durazzo, M., Belci, P., Collo, A., Grisoglio, E., & Bo, S. (2012) · International Journal of Hepatology · doi:10.1155/2012/464706 · Cited by 36
“Several synthetic FXR agonists are studied for the therapy of metabolic and hepatic disorders [92].”
BackgroundPozniak, K. N., Pearen, M. A., Pereira, T. N., Kramer, C. S. M., Croft, P. K., Nawaratna, S. S. K., Fernandez-Rojo, M. A., Gobert, G. N., Tirnitz‐Parker, J. E. E., Olynyk, J. K., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.024 · Cited by 38
“However, their partial hydrophobic nature, which is essential in forming micelles, also makes them toxic to the liver in higher concentrations.(18) The bile salt composition within bile is altered in children with CFLD, as we have previously shown,(19) and is comparable to that of mice following bile duct ligation.”
BackgroundDeoxycholic acid supplementation impairs glucose homeostasis in mice
Zaborska, K. E., Lee, S. A., Garibay, D., Cha, E., & Cummings, B. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200908 · Cited by 36
Zhu, G., & Fěng, F. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.111860 · Cited by 31
Increased levels of conjugated bile acids are associated with human bile reflux gastritis
Zhao, A., Wang, S., Chen, W., Zheng, X., Huang, F., Han, X., Ge, K., Rajani, C., Huang, Y., Yu, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68393-5 · Cited by 38
Zhang, S., Luo, P., Xu, J., Yang, L., Ma, P., Tan, X., Chen, Q., Zhou, M. L., Song, S., Xia, H., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s325853 · Cited by 33
Chen, F., Lin, L., & Zhao, M. (2023) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2023.108472 · Cited by 31
Zhu, J., Ye, Y., Ning, M., Mándi, A., Feng, Y., Zou, Q., Kurtán, T., Leng, Y., & Shen, J. (2013) · ChemMedChem · doi:10.1002/cmdc.201300144 · Cited by 33
Liu, H., Wang, J., Ding, Y., Shi, X., & Ren, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04955-x · Cited by 38
“and pass into the colon, where they are subjected to bacterial metabolism [38].”
BackgroundHuang, W., Peng, Y., & Kang, L. (2024) · View · doi:10.1002/viw.20240010 · Cited by 38
Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
Gitto, S., Vitale, G., Villa, E., & Andreoné, P. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/732870 · Cited by 30
Govindan, J. A., Jayamani, E., Zhang, X. L., Breen, P. C., Larkins‐Ford, J., Mylonakis, E. E., & Ruvkun, G. (2015) · Nature Cell Biology · doi:10.1038/ncb3229 · Cited by 30
Enya, S., Kawakami, K., Suzuki, Y., & Kawaoka, S. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.032383 · Cited by 32
“…that hepatic cyp7a1 , the gene encoding the rate-limiting enzyme that acts at the first step of converting cholesterol to bile acids, in the case of zebrafish, BA (Kuipers et al., 2014; Reschly et al., 2008; Thomas et al., 2008), tended to be reduced in the presence of the intestinal tumor (Fig.”
Oshiro, T., Nagata, S., Wang, C., Takahashi, T., Tsuji, H., Asahara, T., Nomoto, K., Takei, H., Nittono, H., & Yamashiro, Y. (2019) · Biomedicine Hub · doi:10.1159/000502935 · Cited by 32
Hepatoprotective impact of the bile acid receptor TGR5
Merlen, G., Bidault, V., Kahale, N., Glénisson, M., Bedoya, J. U., Doignon, I., Garcin, I., Humbert, L., Rainteau, D. P., & Tordjmann, T. (2020) · Liver International · doi:10.1111/liv.14427 · Cited by 30
Paroxetine Administration Affects Microbiota and Bile Acid Levels in Mice
Dethloff, F., Vargas, F., Elijah, E. O., Quinn, R. A., Park, D. I., Herzog, D. P., Müller, M. B., Gentry, E. C., Knight, R. D., González, A., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00518 · Cited by 32
Jung, Y., Koo, B. K., Jang, S. Y., Kim, D. R., Lee, H., Lee, D. H., Joo, S. K., Jung, Y. J., Park, J. H., Yoo, T., et al. (2021) · Liver International · doi:10.1111/liv.15030 · Cited by 31
Song, Y., Sun, L., Ma, P., Xu, L., & Xiao, P. (2022) · Food & Function · doi:10.1039/d1fo03971g · Cited by 30
Wang, R., Ren, Y., Bao, T., Wang, T., Li, Y., Liu, Y., Zhang, X., Yang, S., & Wang, H. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.02.033 · Cited by 32
Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma
Guo, Y., Peng, Q., Hao, L., Ji, J., Zhang, Z., Xue, Y., Liu, Y., Gao, Y., Li, C., & Shi, X. (2022) · The FASEB Journal · doi:10.1096/fj.202200171r · Cited by 30
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists
Tognolini, M., Incerti, M., Pala, D., Russo, S., Castelli, R., Hassan‐Mohamed, I., Giorgio, C., & Lodola, A. (2013) · ChemMedChem · doi:10.1002/cmdc.201300305 · Cited by 31
Coulombe, G., & Rivard, N. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.11.001 · Cited by 36
The new therapeutic frontier--nuclear receptors and the liver
Karpen, S. J., & Trauner, M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.002 · Cited by 29
“Besides their well-established roles in dietary lipid absorption and cholesterol homeostasis, bile acids (BAs) have also systemic endocrine functions which are mediated by FXR (NR1H4) and the G-protein-coupled receptor TGR5 [36].”
Wang, X., Jin, Y., Di, C., Zeng, Y., Zhou, Y., Chen, Y., Pan, Z., Li, Z., & Ling, W. (2024) · Nutrients · doi:10.3390/nu16081169 · Cited by 32
“…the Farnesoid X Receptor (FXR) and the G protein-coupled receptor 5 (TGR5) are widely presented in the body, and serve as important targets for the biological activity of BAs in the enterohepatic circulation [84,85], with most secondary BAs and conjugated BAs acting as potent FXR agonists [81,86].”
BackgroundThe Role of Selected lncRNAs in Lipid Metabolism and Cardiovascular Disease Risk
Gluba-Brzózka, A., Franczyk, B., Rysz-Górzyńska, A., Olszewski, R., & Rysz, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179244 · Cited by 34
“FXR activity affects diverse metabolic pathways, encompassing bile acid synthesis and lipid homeostasis [65], with activation of this pathway yielding pleiotropic beneficial effects in the context of metabolic disorders [66].”
BackgroundJannati, S., Patel, A., Patnaik, R., & Banerjee, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125521 · Cited by 36
The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know
Pereira, K., Salsamendi, J. T., & Casillas, J. (2015) · Journal of Clinical Imaging Science · doi:10.4103/2156-7514.157860 · Cited by 33
“GS‐9450),[82] glucagon‐like peptide‐1 (Glp‐1),[82,83] and probiotics.”
An UPLC–MS/MS method for quantitative profiling of bile acids in sea lamprey plasma and tissues
Wang, H., Yeh, C., Li, K., Chung‐Davidson, Y., & Li, W. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.12.018 · Cited by 29
Xiong, F., Zheng, Z., Xiao, L., Su, C., Chen, J., Gu, X., Tang, J., Zhao, Y., Luo, H., & Zha, L. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100067 · Cited by 44
Rebelos, E., Iozzo, P., Guzzardi, M. A., Brunetto, M. R., & Bonino, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i30.4999 · Cited by 33
TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present)
Bhimanwar, R. S., & Mittal, A. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.1994551 · Cited by 31
“TGR5 receptor gets activated by bile acid-like LCA, DCA, CDCA, and CA. Bile acids promote intracellularly cAMP production in enteroendocrine cell line STC-1 cells that result in GLP-1 secretion via activation of the TGR5 gene expressed in a murine enteroendocrine cell line [8].”
BackgroundInfluentialLu, X.-R., Ma, N., Liu, X., Li, S., Qin, Z., Bai, L., Yang, Y., & Li, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.733789 · Cited by 29
“In rat liver, the concentrations of 26 BAs including cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), ursodeoxycholic acid (UDCA), hyodeoxycholic acid (HDCA), glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), glycodeoxycholic acid (GDCA), glycoursodeoxycholic acid (GUDCA), glycohyodeox…”
BackgroundMethodInfluentialDing, L., Ren, S., Song, Y., Zang, C., Liu, Y., Guo, H., Yang, W., Guan, H., & Liu, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.935612 · Cited by 36
“Bile acids regulate the absorption of fats and steroids in the gut and act as signaling molecules activated by farnesoid X receptor (FXR) and G-protein-coupled bile acid receptor-1 (GPBAR-1) in the liver, intestine, muscle, and brown adipose tissue (76, 77).”
BackgroundUnraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease
Njeim, R., Alkhansa, S., & Fornoni, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051360 · Cited by 31
Bile Acid Sequestrants: Glucose-Lowering Mechanisms
Prawitt, J., & Staels, B. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0096 · Cited by 32
“36 TGR5 can also activate the mitogen-activated protein kinase (MAPK) pathway.”
Chaudhry, A. S., Thirumaran, R. K., Yasuda, K., Yang, X., Fan, Y., Strom, S. C., & Schuetz, E. G. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.051672 · Cited by 30
“Bile acids are now recognized not just as fat solubilizers, but as signaling hormones with endocrine effects that affect regulation of P450s as well as lipid and glucose metabolism (Houten and Auwerx, 2004; Thomas et al., 2008).”
BackgroundHepatotoxicity of nutmeg: A pilot study based on metabolomics
Cao, Z., Xia, W., Zhang, X., Yuan, H., Guan, D., & Gao, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110780 · Cited by 29
Zhang, K., Yao, Y., Wang, M., Liu, F., Wang, Q., Ma, H., Xie, Y., Ma, Y., Dai, P., Zhu, C., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153683 · Cited by 34
Ogilvie, L. A., Firouzmand, S., & Jones, B. V. (2012) · Bioengineered · doi:10.4161/bbug.3.1.17883 · Cited by 39
Yu, B.-Z., Kaimal, R., Bai, S., Sayed, K. A. E., Tatulian, S. A., Apitz, R. J., Jain, M. K., Deng, R., & Berg, O. G. (2008) · Journal of Natural Products · doi:10.1021/np8004453 · Cited by 28
Metabolic Surgery and Diabesity: a Systematic Review
Khoury, L. E., Chouillard, E. K., Chahine, E., Saikaly, E., Debs, T., & Kassir, R. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3252-6 · Cited by 33
UDCA for NASH: End of the story?
Haedrich, M., & Dufour, J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.009 · Cited by 33
“TGR5 is an important regulator of glucose homeostasis and lipid metabolism and its activation stimulates energy expenditure and protects against obesity [20].”
BackgroundGao, P., Rinott, E., Dong, D., Mei, Z., Wang, F., Liu, Y., Kamer, O., Meir, A. Y., Tuohy, K. M., Blüher, M., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2426610 · Cited by 39
Bugs, guts and brains, and the regulation of food intake and body weight
Hamilton, M. K., & Raybould, H. E. (2016) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2016.3 · Cited by 29
Kim, K. H., Choi, J. M., Li, F., Dong, B., Wooton‐Kee, C. R., Arizpe, A., Anakk, S., Jung, S. Y., Hartig, S. M., & Moore, D. D. (2019) · Hepatology Communications · doi:10.1002/hep4.1274 · Cited by 27
“ABCA11/BSEP is a major canalicular BA transporter that mainly excretes tauro-conjugated and glyco-conjugated BAs into bile.(23) Decreased mRNA and protein levels of ABCB11 in DKO mice were further suppressed in TKO mice (Fig.”
BackgroundBile acid signaling in renal water regulation
Li, S., Li, C., & Wang, W. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00563.2018 · Cited by 30
“Emerging evidence has demonstrated that BAs and BA signaling are important contributors to metabolic regulation and are thus promising therapeutic targets for metabolic diseases (30).”
BackgroundPenman, S. L., Sharma, P., Aerts, H., Park, B. K., Weaver, R. J., & Chadwick, A. E. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104595 · Cited by 29
Petersen, A. Ø., Julienne, H., Hyötyläinen, T., Sen, P., Fan, Y., Pedersen, H., Jäntti, S. E., Hansen, T. H., Nielsen, T., Jørgensen, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91482-y · Cited by 28
Ramireddy, L., Tsen, H., Chiang, Y.-C., Hung, C.-Y., Wu, S.-R., Young, S.-L., Lin, J., Huang, C., Chiu, S., Chen, C., et al. (2021) · Foods · doi:10.3390/foods10122931 · Cited by 28
Hepatic Reduction in Cholesterol 25-Hydroxylase Aggravates Diet-induced Steatosis
Dong, Z., He, F., Yan, X., Xing, Y., Lei, Y., Gao, J., He, M., Li, D., Bai, L., Yuan, Z., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.12.018 · Cited by 30
“However, most bile acids are reabsorbed in the ileum and circulate back to the liver via portal circulation to inhibit CYP7A1 and thereby prevent excessive production of bile acids.(8) This feedback inhibition of bile acid synthesis is mediated by fibroblast growth factor 15 (FGF15)/19 in the ileum and small heterodim…”
BackgroundKadyan, S., Park, G., Wang, B., Singh, P. R., Arjmandi, B. H., & Nagpal, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-37036-w · Cited by 32
Zi, Z., & Rao, Y. (2024) · Science Advances · doi:10.1126/sciadv.adj0146 · Cited by 31
Matysik, S., & Schmitz, G. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.015 · Cited by 28
Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation
Schadt, H. S., Wolf, A., Mahl, J. A., Wuersch, K., Couttet, P., Schwald, M., Fischer, A., Lienard, M., Emotte, C., Teng, C.-H., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy031 · Cited by 26
“Induction of hepatic Cyp7a1 occurs secondary to CHO-mediated intestinal depletion of BAs, which prevents BA-mediated activation of the endocrine FXR-FGF19-FGFR4-KLB pathway (Thomas et al., 2008).”
BackgroundInfluentialAn, J. M., Shahriar, S. M. S., Hwang, Y. H., Hwang, S. R., Lee, D. Y., Cho, S., & Lee, Y.-K. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c22170 · Cited by 27
Lickteig, A. J., Csanaky, I. L., Pratt-Hyatt, M., & Klaassen, C. D. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw054 · Cited by 26
“Given these differences, there is a gradient of hydrophobicity among the predominant BA species: UDCA<CA<CDCA<DCA< LCA (Heuman, 1989; Thomas et al., 2008).”
BackgroundInfluentialLi, J., Huang, Z., Yu, J., Liang, L., Li, Y., Xu, K., Zhou, W., & Li, X. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230907152207 · Cited by 27
Oral Delivery of Gemcitabine-Loaded Glycocholic Acid-Modified Micelles for Cancer Therapy
Zang, W., Gao, D., Yu, M., Long, M., Zhang, Z., & Ji, T. (2023) · ACS Nano · doi:10.1021/acsnano.3c04793 · Cited by 28
“31 Notably, bile acids undergo absorptive processes encompassing both passive and active mechanisms within the distal segments of the small intestine.”
BackgroundSong, T., Liang, X., Wang, H., Xue, M., & Wang, J. (2024) · Animal nutrition · doi:10.1016/j.aninu.2024.03.008 · Cited by 28
Bioactive metabolites: A clue to the link between MASLD and CKD?
Chen, W., Zhang, J.-H., Chen, L., Byrne, C. D., Targher, G., Luo, L., Ni, Y., Zheng, M., & Sun, D. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0782 · Cited by 28
Targeting the gastrointestinal tract to treat type 2 diabetes
Bauer, P. V., & Duca, F. A. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0056 · Cited by 29
Wei, M., Gu, E., Luo, J., Zhang, Z., Xu, D., Tao, X., Shah, N. P., & Wei, H. (2020) · Journal of Dairy Science · doi:10.3168/jds.2019-17185 · Cited by 27
Bishay, R. H., Tonks, K. T. T., George, J., Samocha‐Bonet, D., Meyerowitz‐Katz, G., Chisholm, D. J., James, D. E., & Greenfield, J. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa940 · Cited by 29
“Indeed, previous reports correlated elevated CA (which requires 12α-hydroxylation) with insulin resistance, MAFLD, and diabetes (14, 21, 22) via intestinal absorption of dietary cholesterol and fats.”
BackgroundFeng, Z., Jia, C., Lin, X., Hu, H., Li, S., Li, F., Cui, Q., Chen, Y., Wu, F., & Xiao, X. (2022) · Cell Proliferation · doi:10.1111/cpr.13228 · Cited by 30
Yang, C., Yang, L., Yang, Y., Wan, M., Xu, D., Pan, D., & Sun, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114864 · Cited by 31
Bile acid-controlled transgene expression in mammalian cells and mice
Roessger, K., Hamri, G. C., & Fussenegger, M. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2013.11.003 · Cited by 27
“As a consequence, most metabolite-inducible bacterial repressors are responsive to metabolite concentrations that are within the host's native or pathophysiological range (Thomas et al., 2008).”
BackgroundHepatic Bile Acid Transporters and Drug-induced Hepatotoxicity
Saran, C., & Brouwer, K. L. R. (2023) · Toxicologic Pathology · doi:10.1177/01926233231212255 · Cited by 30
“31 Key factors in assessing bile acid-mediated DILI liability using animal models are species differences in bile acid homeostasis, as well as bile acid transporter expression and function.”
BackgroundMethodDistinct bile acid alterations in response to a single administration of PFOA and PFDA in mice
Yu, X., Zhang, Y., Cogliati, B., Klaassen, C. D., Kumar, S., Cheng, X., & Bu, P. (2024) · Toxicology · doi:10.1016/j.tox.2023.153719 · Cited by 26
Targeting Nuclear Bile Acid Receptors for Liver Disease
Trauner, M., Baghdasaryan, A., Claudel, T., Fickert, P., Halilbasic, E., Moustafa, T., & Zollner, G. (2011) · Digestive Diseases · doi:10.1159/000324141 · Cited by 27
“These findings further support that FXR/agonists could constitute a new avenue for treatment of human chronic cholangiopathies. Nor UDCA, a side chain-shortened homologue of UDCA with convincing therapeutic effects in animal models of cholestasis [ , ,”
BackgroundA novel role for farnesoid X receptor in the bile acid‐mediated intestinal glucose homeostasis
Zhao, L., Xuan, Z., Song, W., Zhang, S., Li, Z., Song, G., Zhu, X., Xie, H., Zheng, S., & Song, P. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15881 · Cited by 28
Probiotics and Their Metabolites Ameliorate Inflammatory Bowel Disease: A Critical Review
Liang, Y., Liu, M., Pu, J., Zhu, Z., Gao, Z., Zhou, Q., Gu, Q., & Li, P. (2020) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000046 · Cited by 28
Yun, Y., Zhang, C., Guo, S., Liang, X., Lan, Y., Wang, M., Zhuo, N., Yin, J., Liu, H., Gu, M., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00851 · Cited by 25
Yue, Z., Chen, Y., Dong, Q., Li, D., Guo, M., Zhang, L., Shi, Y., Wu, H., Li, L., & Sun, Z. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111405 · Cited by 28
Hu, L., Wang, X., Bao, Z., Xu, Q., Qian, M., & Jin, Y. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136141 · Cited by 26
New Insights into Orphan Nuclear Receptor SHP in Liver Cancer
Zou, A., Lehn, S., Magee, N. S., & Zhang, Y. (2015) · Nuclear Receptor Research · doi:10.11131/2015/101162 · Cited by 29
“A number of bile acid-activated signaling pathways have become attractive therapeutic targets for metabolic disorders [42].”
BackgroundMolecular interactions between selected sodium salts of bile acids and morphine hydrochloride
Poša, M., Csanádi, J., Kövér, K. E., GUZSVÁNY, V. J., & Batta, G. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.02.014 · Cited by 25
Sindhu, T., & Srinivasan, P. (2015) · Molecular BioSystems · doi:10.1039/c5mb00137d · Cited by 28
Heidker, R. M., Caiozzi, G. C., & Ricketts, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154305 · Cited by 25
“The classical pathway for BA synthesis accounts for at least 75% of the total BA pool [18].”
Backgroundde Boer, J. F., Schonewille, M., Dikkers, A., Koehorst, M., Havinga, R., Kuipers, F., Tietge, U. J. F., & Groen, A. K. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308558 · Cited by 26
Wang, S., Deng, Y., Xie, X., Ma, J., Xu, M., Zhao, X., Gu, W., Hong, J., Wang, W., Xu, G., et al. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12771 · Cited by 26
“Except for the changes in TCA,26 these changes in the BAs described above are the first reported in T2DM.”
BackgroundInfluentialInsulin alleviates murine colitis through microbiome alterations and bile acid metabolism
He, S., Li, J., Yao, Z., Gao, Z., Jiang, Y., Chen, X., & Peng, L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04214-3 · Cited by 28
“FXR and TGR5 are bile acid receptors, and LCA is the most potent bile acid ligand for TGR5 activation [45].”
BackgroundBile salt signaling and bile salt-based therapies in cardiometabolic disease
Groenen, C., Nguyen, T.-A., Paulusma, C. C., & van de Graaf, S. F. J. (2024) · Clinical Science · doi:10.1042/cs20230934 · Cited by 26
“GLP1 is an insulinotropic gastrointestinal hormone that belongs to the family of incretins and their main physiological role is to amplify glucose-dependent insulin secretion from pancreatic β cells after food ingestion [25].”
BackgroundActivation of TGR5 promotes mitochondrial biogenesis in human aortic endothelial cells
Zhao, L., & Zhang, S.-F. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.210 · Cited by 24
Metabolomics reveals the toxicological effects of polar compounds from frying palm oil
Yuan, L., Jiang, F., Cao, X., Liu, Y., & Xu, Y. (2020) · Food & Function · doi:10.1039/c9fo02728a · Cited by 26
Arshad, M. A., Faiz-ul-Hassan, Bhatti, S. A., Rehman, M. S.-U., Yousaf, W., Younus, G., Sızmaz, Ö., & Bilal, M. Q. (2020) · Annals of Animal Science · doi:10.2478/aoas-2020-0099 · Cited by 29
Bile acid indices as biomarkers for liver diseases I: Diagnostic markers
Alamoudi, J. A., Li, W., Gautam, N., Olivera, M. A., Meza, J. L., Mukherjee, S., & Alnouti, Y. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i4.433 · Cited by 24
Charkoftaki, G., Tan, W. Y., Berríos‐Cárcamo, P., Orlicky, D. J., Golla, J. P., García-Milian, R., Aalizadeh, R., Τhomaidis, Ν. S., Thompson, D. C., & Vasiliou, V. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109931 · Cited by 32
Targeted metabolomics reveals aberrant profiles of serum bile acids in patients with schizophrenia
Qing, Y., Wang, P., Cui, G., Zhang, J., Liang, K., Xia, Z., Wang, P., He, L., & Jia, W. P. (2022) · Schizophrenia · doi:10.1038/s41537-022-00273-5 · Cited by 27
Chen, K., Gao, Z., Ding, Q., Tang, C., Zhang, H., Zhai, T., Xie, W., Jin, Z., Zhao, L., & Liu, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.962720 · Cited by 34
“In the gastrointestinal tract, primary BAs can be further transformed Frontiers in Nutrition 03 frontiersin.org fnut-09-962720 October 28, 2022 Time: 10:57 # 4 Chen et al. 10.3389/fnut.2022.962720 into secondary BAs by conjugation to glycine or taurine through bile salt hydrolase (BSH) derived from genera Bacteroides,…”
BackgroundInfluentialEffects of Perfluorooctanoic Acid on Gut Microbiota and Microbial Metabolites in C57BL/6J Mice
Gao, B., Chen, L., Xu, W., Shan, J., Shen, W., & Gao, N. (2023) · Metabolites · doi:10.3390/metabo13060707 · Cited by 28
“Bile acids are recognized as signaling factors and metabolic integrators, and they have become therapeutic targets for diseases such as metabolic disorder [18].”
BackgroundPan, X., Lee, Y., & Jeong, H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064758 · Cited by 26
“BA Many FXR agonists are currently under development for different hepatic or metabolic diseases, including primary biliary cirrhosis, nonalcoholic steatohepatitis, and diabetes (Thomas et al., 2008).”
BackgroundContinuous flow synthesis and scale-up of glycine- and taurine-conjugated bile salts
Venturoni, F., Gioiello, A., Sardella, R., Natalini, B., & Pellicciari, R. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25528f · Cited by 26
Self-citation
Metadata
- Authors
- Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K.
- Affiliations
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- University of Perugia (IT)
- Intercept Pharmaceuticals (United States) (US)
- Corresponding author
- Auwerx, Johan
- Schoonjans, Kristina
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-08
- Volume
- 7
- Issue
- 8
- Pages
- 678-693
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2078810890
- Cited by
- 1,422
- References
- 169
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 106 · 2023: 107 · 2022: 113 · 2021: 90 · 2020: 83 · 2019: 82 · 2018: 78 · 2017: 81 · 2016: 75 · 2015: 75 · 2014: 71 · 2013: 77 · 2012: 47
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- European Commission
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Société Française de Nutrition
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Keywords
- bile acids, bile acid signaling, metabolic disorders, obesity, type 2 diabetes, hypertriglyceridemia, atherosclerosis, nonalcoholic steatohepatitis, therapeutic target, drug development
- MeSH terms
- Animals, Bile Acids and Salts, Humans, Metabolic Diseases, Signal Transduction, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.